文献速递中医内科中药与中成药合理使用

台湾帕金森病非运动症状的中药使用:基于人群研究

Chinese Herbal Products for Non-Motor Symptoms of Parkinson's Disease in Taiwan: A Population-Based Study.
PubMed 文献 · Front Pharmacol · 2021-01-27

本研究基于台湾全民健康保险研究数据库随机抽取一百万人中的9,117名帕金森病患者,分析中药复方与单味药的使用模式。最常用复方为柴胡加龙骨牡蛎汤,其次为麻子仁丸和芍药甘草汤;最常用单味药为猫爪草(Uncaria tomentosa),其次为天麻和大黄。结论提示柴胡加龙骨牡蛎汤与猫爪草最常用于帕金森病,其疗效、不良反应及神经保护机制需进一步研究。

要点

  • 台湾帕金森病患者最常用中药复方为柴胡加龙骨牡蛎汤。
  • 最常用单味药为猫爪草,其次为天麻和大黄。
  • 中药使用者多为女性、较年轻、白领及中部地区居民。

核心结论

  • 柴胡加龙骨牡蛎汤与猫爪草是台湾帕金森病患者最常用的中药,其疗效、不良反应及神经保护机制尚待进一步研究。

研究设计与样本

  • 本研究为基于人群的队列研究,分析台湾全民健康保险研究数据库随机抽取一百万人中的9,117名帕金森病患者。
  • 采用多元逻辑回归模型估计人口学因素的调整比值比,并分析常用复方与单味药。

主要发现

  • 中药使用者更常见为女性、较年轻、白领及台湾中部居民。
  • 最常用复方依次为柴胡加龙骨牡蛎汤、麻子仁丸、芍药甘草汤。
  • 最常用单味药依次为猫爪草、天麻、大黄。
  • 柴胡加龙骨牡蛎汤与猫爪草在既往研究中显示神经保护作用,并用于管理帕金森病非运动症状。

临床怎么用

  • 本研究结果揭示台湾帕金森病的中药处方偏好,可作临床用药参考,但疗效与安全性需进一步验证。

局限性

  • 原文未明确报告局限性,需进一步研究确定这些中药改善帕金森病各种症状的有效性、不良反应及神经保护机制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: Combinations of Chinese herbal products (CHPs) are widely used for Parkinson's disease (PD) in Taiwan. Thereby, we investigated the use of CHPs in patients with PD. Methods: This study was a population-based cohort study that analyzed the data of patients with PD from the National Health Insurance Research Database. A total of 9,117 patients were selected from a random sample of one million individuals included in this database. We used multiple logistic regression models to estimate the adjusted odds ratios of the demographic factors and analyzed the formula and single CHPs commonly used for PD. Results: Traditional Chinese medicine users were more commonly female, younger, of white-collar status, and residents of Central Taiwan. Chaihu-Jia-Longgu-Muli-Tang was the most commonly used formula, followed by Ma-Zi-Ren-Wan and then Shao-Yao-Gan-Cao-Tang. The most commonly used single herb was Uncaria tomentosa (Willd. ex Schult.) DC., followed by Gastrodia elata Blume and then Radix et Rhizoma Rhei (Rheum palmatum L., Rheum tanguticum Maxim. ex Balf., and Rheum officinale Baill.). Chaihu-Jia-Longgu-Muli-Tang and U. tomentosa (Willd. ex Schult.) DC. have shown neuroprotective effects in previous studies, and they have been used for managing non-motor symptoms of PD. Conclusion: Chaihu-Jia-Longgu-Muli-Tang and U. tomentosa (Willd. ex Schult.) DC. are the most commonly used CHPs for PD in Taiwan. Our results revealed the preferences in medication prescriptions for PD. Further studies are warranted to determine the effectiveness of these CHPs for ameliorating the various symptoms of PD, their adverse effects, and the mechanisms underlying their associated neuroprotective effects.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Lin CH, Chiu HE, Wu SY, et al. Chinese Herbal Products for Non-Motor Symptoms of Parkinson's Disease in Taiwan: A Population-Based Study. Front Pharmacol. 2021. PMID: 33584294. doi:10.3389/fphar.2020.615657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。